The DZIF is also developing a COVID-19 vaccine candidate based on MVA as a viral vector for the SARS-CoV-2 S protein, and protective efficacy against MERS infection has previously been demonstrated in mice (136) and camels (137). This evidence concerns the gene PROS1 and COVID-19.